Aurora Cannabis Inc (TSE:ACB) was the target of a large growth in short interest in the month of October. As of October 31st, there was short interest totalling 72,713,568 shares, a growth of 23.9% from the October 15th total of 58,691,862 shares. Based on an average trading volume of 26,867,748 shares, the short-interest ratio is presently 2.7 days.

Several equities analysts have recently weighed in on the stock. Canaccord Genuity raised their target price on shares of Aurora Cannabis from C$11.00 to C$13.00 in a research note on Wednesday, September 26th. Eight Capital restated a “buy” rating and set a C$9.00 target price on shares of Aurora Cannabis in a research note on Thursday, August 2nd.

An institutional investor recently bought a new position in Aurora Cannabis stock. Gulf International Bank UK Ltd bought a new position in shares of Aurora Cannabis Inc (TSE:ACB) in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 11,669 shares of the company’s stock, valued at approximately $112,000.

Shares of ACB opened at C$9.36 on Friday. The company has a debt-to-equity ratio of 13.00, a current ratio of 2.92 and a quick ratio of 2.18. Aurora Cannabis has a 1 year low of C$4.06 and a 1 year high of C$16.24.

Aurora Cannabis (TSE:ACB) last posted its earnings results on Tuesday, September 25th. The company reported C$0.17 earnings per share for the quarter, beating analysts’ consensus estimates of C($0.04) by C$0.21. The business had revenue of C$19.15 million during the quarter, compared to analysts’ expectations of C$23.01 million. Sell-side analysts expect that Aurora Cannabis will post 0.16 EPS for the current fiscal year.

TRADEMARK VIOLATION NOTICE: “Aurora Cannabis Inc (ACB) Sees Significant Growth in Short Interest” was originally reported by TheOlympiaReport and is owned by of TheOlympiaReport. If you are reading this story on another website, it was illegally copied and republished in violation of US and international trademark & copyright legislation. The correct version of this story can be read at

About Aurora Cannabis

Aurora Cannabis Inc is a Canada-based company engaged in the production and distribution of medical cannabis. The Company is vertically integrated and horizontally diversified across every key segment of the value chain, from facility engineering and design to cannabis breeding and genetics research, cannabis and hemp production, derivatives, home cultivation, wholesale and retail distribution.

Featured Story: Can individual investors take part in an IPO?

Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with's FREE daily email newsletter.